Are you living with type 2 diabetes?

The ReCET Study may be right for you.

Are you living with type 2 diabetes?

The ReCET Study may be right for you.

What is the ReCET Study?

The ReCET Study is evaluating a non-surgical, same day procedure that may help people with type 2 diabetes improve their blood sugar levels.

Who can join the ReCET Study?

You may be able to join the study if you meet the following requirements:

22-70 years of age

Not using insulin

Taking 2 to 4 blood sugar control medications

Diagnosis of
type 2 diabetes for at least 6 months

Other study requirements will apply. If you choose to participate, the study doctors will provide more information.

Participation in a clinical study is voluntary. You can ask any questions you have and may leave the study at any time, for any reason.

About the ReCET Procedure

What is the ReCET Procedure?

The ReCET Procedure is a non-surgical, investigational treatment designed to reduce blood sugar levels and improve glycemic control in adults with type 2 diabetes. During the procedure, a doctor introduces a small camera through the mouth to place a specialized device (catheter) in the duodenum (the first part of the small intestine). The catheter then delivers highly controlled electric energy to the lining of the duodenum. This energy triggers the body’s natural process to regenerate healthy cells that can help control blood sugar levels. The camera and catheter are then removed, and nothing is left inside the body.

Following routine observation, the patient can return home the same day and resume normal activities shortly after.

What does "investigational" mean in research?

Investigational means the ReCET™ System can only be used in clinical research studies. Use outside these studies is not approved by regulatory authorities like the U.S. Food and Drug Administration (FDA) or Therapeutic Goods Administration (TGA) in Australia.

ReCET Procedure Video

Patient Testimonial

About Type 2 Diabetes (T2D)

What is type 2 diabetes?

Type 2 diabetes (T2D) currently impacts over 400 million people worldwide. People with type 2 diabetes can have difficulty managing their blood sugar levels. This can be damaging to the body and cause other serious health issues.

Living with type 2 diabetes can be challenging. The ReCET Procedure being offered in this study is designed to reduce blood sugar levels and may help get your diabetes under control.

Overview of Clinical Trials

Here are some common questions and answers about study participation.

Study Center Locations

Caution: Investigational Device. Limited by Federal (or United States) Law to Investigational Use. Exclusively for clinical investigation. NOT FOR SALE IN ANY GEOGRAPHY. ReCET is a trademark of Endogenex, Inc. © Endogenex, Inc. 2024 All Rights Reserved.  
This product, and its use, may be protected by U.S. Patents and pending applications.
Copyright © 2024 Medpace | Stock Photos Posed by Models